|
| Press Releases |
|
 |
|
| Thursday, June 21, 2018 |
|
|
HKBU scholars invent award-winning medical device for safe growth of neural stem cells using nanotechnology |
| The research team of Hong Kong Baptist University (HKBU) invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells (NSCs) in vitro. more info >> |
|
| Wednesday, May 16, 2018 |
|
|
HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker |
| A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University (HKBU) has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells. more info >> |
|
| Tuesday, May 23, 2017 |
|
|
Research jointly led by HKBU and HKUST decoding the first deep-sea mussel genome published in Nature Ecology & Evolution |
| Joint research led by Hong Kong Baptist University (HKBU) and the Hong Kong University of Science and Technology (HKUST) has assembled the 1.64 gigabytes genome of a deep-sea mussel, which is roughly equivalent to 50% of the size of human genome. more info >> |
|
| Thursday, May 18, 2017 |
|
|
HKBU Chinese Medicine Scholars Conduct Research in Space Life Science aboard China's Tianzhou 1 |
| The School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) is conducting a space life science study on board China's first cargo spacecraft, Tianzhou-1, which was launched last month. HKBU is the only higher education institution from outside of Mainland to conduct a scientific research project onboard Tianzhou-1. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
益美国际(01870.HK) 优化供应链 加速储能产品布局 夯实全球产业能力
Mar 27, 2026 21:35 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 27, 2026 19:40 HKT/SGT
|
|
|
Xunce Technology's Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?
Mar 27, 2026 19:19 HKT/SGT
|
|
|
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
Mar 27, 2026 20:14 JST
|
|
|
迅策科技業績環比激增449% 結構性重估或進入千億市值陣營？
Mar 27, 2026 19:12 HKT/SGT
|
|
|
迅策科技业绩环比激增449% 结构性重估或进入千亿市值阵营？
Mar 27, 2026 19:04 HKT/SGT
|
|
|
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility
Mar 27, 2026 19:44 JST
|
|
|
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million
Mar 27, 2026 18:38 HKT/SGT
|
|
|
安樂工程公佈2025年全年業績 本公司擁有人應佔溢利增23.5%至1.670億港元
Mar 27, 2026 18:29 HKT/SGT
|
|
|
安乐工程公布2025年全年业绩 本公司拥有人应占溢利增23.5%至1.670亿港元
Mar 27, 2026 18:18 HKT/SGT
|
|
|
多維驅動全域突破 海天味業2025年交出高品質發展成績單
Mar 27, 2026 18:08 HKT/SGT
|
|
|
多维驱动全局突破 海天味业2025年交出高质量发展成绩单
Mar 27, 2026 17:57 HKT/SGT
|
|
|
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
Mar 27, 2026 18:19 JST
|
|
|
美麗田園2025年報重磅發佈！經調淨利潤大增41% 現金牛實力凸顯
Mar 27, 2026 16:40 HKT/SGT
|
|
|
New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation
Mar 27, 2026 16:51 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
